Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced HCC: the dark side of the moon.
Giuseppe CabibboCiro CelsaEleonora AlimentiMassimo IavaronePublished in: Hepatology (Baltimore, Md.) (2023)
Keyphrases